C4 Therapeutics, Inc.: cashflow_investing

Value{"amount": -184000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2020-01-01 – 2020-03-31
Statuscurrent
EntityC4 Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-21-027606
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001662579/cashflow-investing/2020-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/26878e23-5c22-4340-8841-080c2137b165

History